MTOR and glomerulosclerosis: Recent studies have shown that complete ablation/inhibition of mTORC1 in podocytes resulted in increased vulnerability and glomerulosclerosis, in contrast to the reported therapeutic health benefits of mTOR inhibitors or just genetic lowering of mTOR level (92).